Treatment of sexually transmitted diseases in women.
Guidelines for the treatment of patients with sexually transmitted infection are developed by the Centers for Disease Control and Prevention after consultation with a group of professionals knowledgeable in the field. This article briefly introduces various infections, reviews new diagnostic information, and presents the latest guidelines for therapy. All recommended and alternative regimens are drawn from the most recent treatment guidelines. Although this article focuses primarily on therapy, it also emphasizes the importance of counseling and prevention. Clinicians have the opportunity and obligation to provide education and counseling to patients. Prevention messages should be tailored to the individual patient with consideration given to her specific risk behaviors.
Hollier
Lisa M
LM
Department of Obstetrics and Gynecology and Reproductive Sciences, University of Texas Houston Medical Center, Lyndon B. Johnson General Hospital, 5656 Kelley Street, Houston, TX 77026, USA. Lisa.M.Hollier@uth.tmc.edu
Workowski
Kimberly
K
D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy; D002602:Chancroid / Q000175:diagnosis / Q000188:drug therapy; D002690:Chlamydia Infections / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006069:Gonorrhea / Q000175:diagnosis / Q000188:drug therapy; D006558:Herpes Genitalis / Q000188:drug therapy; D006801:Humans; D010373:Lice Infestations / Q000188:drug therapy; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011247:Pregnancy; D012532:Scabies / Q000188:drug therapy; D012749:Sexually Transmitted Diseases / Q000175:diagnosis / Q000382:microbiology / Q000469:parasitology / Q000628:therapy*; D013587:Syphilis / Q000175:diagnosis / Q000188:drug therapy; D014247:Trichomonas Vaginitis / Q000175:diagnosis / Q000188:drug therapy; D002575:Uterine Cervicitis / Q000188:drug therapy / Q000382:microbiology; D016585:Vaginosis, Bacterial / Q000175:diagnosis / Q000188:drug therapy